CAT No: CP26500
CAS No:17057-07-7
Synonyms/Alias:17057-07-7;3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)benzoicacid;3-(2,5-Dioxo-2,5-dihydro-pyrrol-1-yl)-benzoicacid;3-n-maleimidobenzoicacid;n-(3-benzoicacid)maleimide;3-(2,5-Dioxo-2,5-dihydro-pyrrol-1-yl)benzoicacid;MLS003107101;CHEMBL441433;3-CARBOXYPHENYLMALEIMIDE;ZJGBFJBMTKEFNQ-UHFFFAOYSA-N;3-(2,5-dioxo-2,5-dihydropyrrol-1-yl)benzoicacid;3-(2,5-dioxopyrrol-1-yl)benzoicacid;3-(2,5-dioxo-2,5-dihydro-1h-pyrrol-1-yl)-benzoicacid;F1265-0504;Benzoicacid,3-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-;3-(2,5-dioxoazolinyl)benzoicacid;NSC201626;m-Maleimidobenzoicacid;PubChem11836;AC1L3CLN;m-n-maleimidobenzoicacid;AC1Q5U3L;AC1Q72TD;AC1Q73IJ;SCHEMBL522308
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
4. Implications of ligand-receptor binding kinetics on GLP-1R signalling
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.